Posters

SFPT Avril 2017 (Rouen)

• Gaboriau, F. Saudemont, C. Pageot, L. Thomas, M. Auffret, S. Gautier. Proton pump inhibitors and vitamin K antagonists resistance: about an unknown interaction? (poster PS2 – 032)
• Deleval I, Gaboriau L, Gautier S, Béné J. Direct Oral Anticoagulants appropriateness’ prescriptions in a French University Hospital Center in 2016. (Poster PS1-031)
• Béné J, Louise G, Decaudin B, Gautier S. Direct Oral Anticoagulants appropriateness’ prescriptions in 2016: analysis from community pharmacies. (Poster, PS1-030)
• Yelnik C., Gaboriau L., Théophile H., Scalbert C., Delaporte E., Gautier S., Lambert M. TNF-α Inhibitors and Psychotic Side Effects: Results from the French Pharmacovigilance Database (Communication orale CO-027)
• M Auffret, B Rolland, S Deheul, H Behal, J Labreuche, S Gautier. Use of multiple sources and capture-recapture method to estimate the number of patients treated with baclofen for alcohol dependence in 2013 in a French region. (poster PM2 – 013)
• E Musy, M Auffret, L Gaboriau, S Deheul, R Bordet, B Rolland, S Gautier. Sexual dysfunctions induced by off label use of baclofen for alcohol dependence: report of 14 cases. (poster PM2 – 014)
• E Matusik, M Auffret, L Gaboriau, S Gautier. Off label use of clonidine in children and adolescents: safety data from French Pharmacovigilance Database (poster PS2 – 014)
• M Auffret, L Gaboriau, L Carton, A Richard, L Vallee, S Gautier. Off-label use of clonidine in children and adolescent for attentiondeficit/hyperactivity disorder in France: a study among pediatric neurologists and child and adolescent psychiatrists using the French pharmacovigilance network (poster PS2 – 015)

Hopipharm Mai 2017

• Thillard EM, Denis-Prévot M, Auffret M, Gaboriau L.Interactions médicamenteuses avec le sorbitol: des alertes informatiques, un risque anecdotique ! » (poster 000445)

EACPT 2017 

• Béné J, Dubart AE, Senis C, Bordet R, Gautier S. Admission to emergency room during direct oral anticoagulation therapy: observational study from 2012 to 2016 in a french hospital (Poster).
• E Matusik, C Pagnucco, A Amad, M Auffret, S Gautier. Lymphoma induced by clozapine ? Data analysis of the French and the WHO pharmacovigilance databasis (poster)
• M. Denis Prevot, M. Auffret, J. Béné, B. Nelken, R. Bordet, S. Gautier. IMATINIB INDUCED PORPHYRIA: CASE REPORT AND LITERATURE REVIEW (poster)

Articles

Publications internationales :

• Auffret M, Labreuche J, Duhamel A, Deheul S, Cottencin O, Bordet R, Gautier S, Rolland B. Authors’ Reply to Alain Braillon’s Comment on « Proactive regional pharmacovigilance system versus national spontaneous reporting for collecting safety data on concerning off-label prescribing practices: An example with baclofen and alcohol dependence in France ». Drug Saf. 2017 Apr;40(4):361-362.
• Auffret M, Labreuche J, Duhamel A, Deheul S, Cottencin O, Bordet R, Gautier S, Rolland B. Proactive Regional Pharmacovigilance System Versus National Spontaneous Reporting for Collecting Safety Data on Concerning Off-Label Prescribing Practices: An Example with Baclofen and Alcohol Dependence in France. Drug Saf. 2017 Mar;40(3):257-262.
• Rolland B, Auffret M, Labreuche J, Lapeyre-Mestre M, Dib M, Kemkem A, Grit I, Drelon M, Duhamel A, Cabe N, Vabret F, Guillin O, Baguet A, Masquelier C, Dervaux A, Deheul S, Bordet R, Carton L, Cottencin O, Jardri R, Gautier S. Phone-based safety monitoring of the first year of baclofen treatment for alcohol use disorder: the BACLOPHONE cohort study protocol. Expert Opin Drug Saf. 2017 Feb;16(2):125-132.
• Carlier P, Bernard N, Lagarce L, Dautriche A, Béné J, Fouilhé Sam-Lai N, Eftekhari P. Pregnancy outcome among partners of male patients receiving imatinib, dasatinib or nilotinib in chronic myeloid leukemia: reports collected by the French network pharmacovigilance centers. Arch Gynecol Obstet. 2017 Feb;295(2):269-271.
• Pétrault M, Gautier S, Bérézowski V, Ouk T, Bastide M, Pétrault O, Bordet R. Neither nefopam nor acetaminophen can be used as postoperative analgesics in a rat model of ischemic stroke. Fundam Clin Pharmacol. 2017 Apr;31(2):194-200. doi: 10.1111/fcp.12246.

Publications françaises :

• Agier MS, Marchand S, Paret N, Gautier S, Jonville-Béra AP. Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr. 2017. pii: S0929-693X(17)30044-1.
• Rochoy M, Auffret M, Béné J, Gautier S; Réseau français des centres régionaux de pharmacovigilance. [Antiemetics and cardiac effects potentially linked to prolongation of the QT interval: Case/non-case analysis in the national pharmacovigilance database].Rev Epidemiol Sante Publique. 2017 Feb;65(1):1-8.